Ishita Drugs and Industries Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023
For the six months, sales was INR 74.81 million compared to INR 61.89 million a year ago. Revenue was INR 76.51 million compared to INR 62.78 million a year ago. Net income was INR 3.47 million compared to INR 2.83 million a year ago. Basic earnings per share from continuing operations was INR 1.162 compared to INR 0.948 a year ago. Diluted earnings per share from continuing operations was INR 1.162 compared to INR 0.948 a year ago.